Financial insights of NXTS

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31
Research and development expenses	275	45*
General and administrative expenses, exclusive of depreciation and amortization	1,899	1,277*
Change in fair value of contingent consideration	343	284*
Goodwill impairment	6,291	-
Depreciation and amortization	103	20*
Operating loss	-8,225	-1,057*
Financing expense, net (note 19)	-	-386*
Financing expense, net	-100	-
Other income	386	453*
Changes in fair value of investments measured under the fair value option (notes 5, 6, 7)	492	88*
Net loss before tax	-7,447	-903*
Income taxes	-23	-4*
Net loss from continuing operation	-7,424	-899*
Net gain (loss) from discontinued operations (note 8)	835	-140*
Net loss	-6,589	-1,039*
Less net loss attributable to non-controlling interests	-9	-38*
Net loss attributable to the companys stockholders equity	-6,580	-1,001

Basic EPS	-10.74	-0.884
Diluted EPS	-10.74	-0.777
Basic Average Shares	612,715	1,132,707
Diluted Average Shares	612,715	1,288,249

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.